Serratia marcescens

Serratia marcescens

''Serratia marcescens'' is a species of rod-shaped, Gram-negative bacteria in the family Yersiniaceae. It is a facultative anaerobe and an opportunistic pathogen. It was discovered in 1819 by Bartolomeo Bizio in Padua, Italy. ''S. marcescens'' is commonly involved in hospital-acquired infections , particularly catheter-associated bacteremia, urinary tract infections, and wound infections, and is responsible for 1.4% of HAI cases in the United States. It is commonly found in the respiratory and urinary tracts of hospitalized adults and in the gastrointestinal systems of children.
Due to its abundant presence in the environment, and its preference for damp conditions, ''S. marcescens'' is commonly found growing in bathrooms , where it manifests as a pink, pink-orange, or orange discoloration and slimy film feeding off phosphorus-containing materials or fatty substances such as soap and shampoo residue.

Once established, complete eradication of the organism is often difficult, but can be accomplished by application of a bleach-based disinfectant. Rinsing and drying surfaces after use can also prevent the establishment of the bacterium by removing its food source and making the environment less hospitable.

''S. marcescens'' may also be found in environments such as dirt, supposedly "sterile" places , and the subgingival biofilm of teeth. Due to this, and because ''S. marcescens'' produces a reddish-orange tripyrrole pigment called prodigiosin, it may cause staining of the teeth. The biochemical pathway for the production of prodigiosin by ''S. marcescens'' has been characterized by analyzing what intermediates become accumulated in specific mutants.
Nymph infected with Serratia marcescens This nymph was alive when I collected it, but before long, it turned red and died. Serratia marcescens is a pathogenic bacteria. It can infect insects, spreads quickly, and is difficult to eradicate. I once lost an entire mosquito colony to this bacteria, which set my research back months.

Habitat: Collected in a woodland stream Geotagged,Serratia,Serratia marcescens,United States,bacteria,infected mayfly nymph,infected nymph,mayfly nymph,nymph

Appearance

''S. marcescens'' is a motile organism and can grow in temperatures ranging from 5–40 °C and in pH levels ranging from 5 to 9. It is differentiated from other Gram-negative bacteria by its ability to perform casein hydrolysis, which allows it to produce extracellular metalloproteinases which are believed to function in cell-to-extracellular matrix interactions. Since this bacterium is a facultative anaerobe, meaning that it can grow in either the presence of oxygen or in the absence of oxygen , it is capable of nitrate reduction under anaerobic conditions. Therefore, nitrate tests are positive since nitrate is generally used as the final electron acceptor rather than oxygen. ''S. marcescens'' also exhibits tyrosine hydrolysis and citrate degradation. Citrate is used by ''S. marcescens'' to produce pyruvic acid, thus it can rely on citrate as a carbon source and test positive for citrate utilization. In identifying the organism, one may also perform a methyl red test, which determines if a microorganism performs mixed-acid fermentation. ''S. marcescens'' results in a negative test. Another determination of ''S. marcescens'' is its capability to produce lactic acid by oxidative and fermentative metabolism. Therefore, ''S. marcescens'' is lactic acid O/F+.

Defense

Until the 1950s, ''S. marcescens'' was erroneously believed to be a nonpathogenic "saprophyte", and its reddish coloration was used in school experiments to track infections. During the Cold War, it was used as a simulant in biological warfare testing by the U.S. military, which studied it in field tests as a substitute for the tularemia bacterium, which was being weaponized at the time.

On 26 and 27 September 1950, the U.S. Navy conducted a secret experiment named "Operation Sea-Spray" in which balloons filled with ''S. marcescens'' were released and burst over urban areas of the San Francisco Bay Area in California. Although the Navy later claimed the bacteria were harmless, beginning on September 29, 11 patients at a local hospital developed very rare, serious urinary tract infections. One of the afflicted patients, Edward J. Nevin, died. Cases of pneumonia in San Francisco also increased after ''S. marcescens'' was released. Nevin's son and grandson lost a lawsuit they brought against the government between 1981 and 1983, on the grounds that the government is immune, and that the chance that the sprayed bacteria caused Nevin's death was minute. The bacterium was also combined with phenol and an anthrax simulant and sprayed across south Dorset by US and UK military scientists as part of the DICE trials which ran from 1971 to 1975.

Since 1950, ''S. marcescens'' has steadily increased as a cause of human infection, with many strains resistant to multiple antibiotics. The first indications of problems with the influenza vaccine produced by Chiron Corporation in 2004 involved ''S. marcescens'' contamination.

References:

Some text fragments are auto parsed from Wikipedia.

Taxonomy
KingdomBacteria
DivisionProteobacteria
ClassGammaproteobacteria
OrderEnterobacterales
FamilyYersiniaceae
GenusSerratia
SpeciesS. marcescens